Eternal founder Deepinder Goyal has announced the expansion of his longevity-focused initiative, Continue Research, with a $25 million fund backed personally to support researchers who “dare to ask simpler questions” about biology and aging. The move builds on a two-year research effort under Continue that has pursued the idea that the human body, viewed as a system, has “leverage points” that could fundamentally influence how we age.
From hypothesis to a wider mission
According to Goyal, Continue began as a research program two years ago, centered on a “penny-drop insight” into human aging, something “hiding in plain sight.” He says the team is at the tail end of research on this hypothesis, and promises to share more “in a few weeks.” While details of the hypothesis are being held back for now, the expansion signals a broader intent: turning a focused internal inquiry into a global push for rigorous, high-leverage research that favors clarity over complexity.
“If the human body is a system, it should also have its leverage points—the simple levers that, when adjusted, could fundamentally alter how we age and live,” Goyal wrote, describing the intellectual spine of Continue’s work to date.
A bet on scientific simplicity
The new fund is aimed at researchers worldwide who believe “biology might be far simpler than we’ve made it.” The framing is as much philosophical as it is practical: strip the questions down; look for the shortest path to cause and effect. By design, it’s a contrarian stance in a field that often leans into ever-growing complexity.
The fund will support those “who dare to ask simpler questions than anyone else,” Goyal said, positioning Continue Research as a champion of first-principles biology.
Longevity as a lever on society
Goyal casts the initiative against a bigger canvas: human decision-making and the time horizons that shape it. He argues that many of the world’s problems trace back to our short lifespans and that extending healthy human function could help people and institutions think beyond the near term.
“For over a decade, I have believed that most of the world’s problems stem from our short human lifespans.”
Continue Research’s goal, he adds, is to extend healthy function “long enough that humans stop making short-term decisions.”
The ambition is explicitly multi-decadal. Goyal describes Continue’s role as a “small catalyst” in humanity’s “journey of conscious evolution,” and hints at a future he calls the “Post-Darwin era.” In other words: push aging research forward not only to add years to life, but to change how societies plan and act.
Open call to researchers
Continue Research has opened its doors to applicants globally. Researchers interested in funding and grants can apply via continue.com/researchers. The organization’s broader purpose and context are outlined at continue.com.
Goyal clarified that Continue is not a part of Eternal. While he signs off as “Founder – Eternal,” he emphasizes that this announcement pertains to Continue Research as a distinct effort.
In the coming weeks, Continue Research plans to share outcomes from its two-year inquiry into a simple but potentially field-shifting idea about aging. For now, the $25 million commitment signals that the project is moving from closed-door research to open collaboration, inviting scientists who share its first-principles mindset to test bold hypotheses with discipline and speed.
Also Read: Statiq Accelerates EV Push with $15-18 Million Funding Round
